Evofem Biosciences
EVFM
$0.01675
Share price
17.96%
Change (1 day)
-16.25%
Change (1 year)
Categories
Evofem Biosciences (EVFM) - P/B ratio
P/B ratio as of April 2024 : -0.0141
According to Evofem Biosciences
's latest financial reports the company has a price-to-book ratio of -0.0141.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Evofem Biosciences - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -0.0103 | -86.45% |
| 2022-12-31 | -0.0762 | -87.57% |
| 2021-12-31 | -0.6128 | -100.42% |
| 2020-12-31 | 145 | 665.58% |
| 2019-12-31 | 19.0 | -509.34% |
| 2018-12-31 | -4.64 | 1612.57% |
| 2017-12-31 | -0.2710 | -120.84% |
| 2016-12-31 | 1.30 | 61.92% |
| 2015-12-31 | 0.8028 | -48.78% |
| 2014-12-31 | 1.57 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6322 | -4,582.23% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.44 | -10,310.16% | 🇺🇸 USA |